Form 8-K - Current report:
SEC Accession No. 0001193125-11-288630
Filing Date
2011-10-31
Accepted
2011-10-31 15:51:54
Documents
3
Period of Report
2011-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d251175d8k.htm 8-K 14971
2 PRESS RELEASE d251175dex991.htm EX-99.1 8252
3 GRAPHIC g251175img001.jpg GRAPHIC 6154
  Complete submission text file 0001193125-11-288630.txt   32987
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 111168259
SIC: 2836 Biological Products, (No Diagnostic Substances)